ACHV vs PRPO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ACHV Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Achieve Life Sciences, Inc. (ACHV) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while PRPO counters with relative strength in Valuation. Fundamentally, ACHV trades at 35.3x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PRPO at 15.4x Forward P/E and -5.3% operating margin (+8.3% YoY). In options structure, ACHV sits in BREAKOUT (23rd %ile IV; Dealer Gamma Walls on Pro) against PRPO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACHV | PRPO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $692.8M | $40.2M | Larger Scale | ACHV |
| Trailing P/E Ratio Valuation | 35.3x | 15.4x | Lower Multiple | PRPO |
| Forward P/E Ratio Valuation | 35.3x | 15.4x | Lower Multiple | PRPO |
| Revenue Growth (YoY) Growth | +0.0% | +8.3% | Higher Growth | PRPO |
| Operating Margin (TTM) Profitability | 0.0% | -5.3% | Higher Margin | ACHV |
| Net Profit Margin Profitability | 0.0% | -4.1% | Higher Margin | ACHV |
| Return on Equity (ROE) Capital Efficiency | -845.0% | -8.0% | Higher ROE | PRPO |
| 52-Week Range Position Momentum | 69% ($3โ$9) | 16% ($18โ$34) | Stronger Trend | ACHV |
| Beta / 30D Volatility Risk Regime | 1.73ฮฒ ยท 62% Vol | 1.21ฮฒ ยท 96% Vol | Lower Realized Risk | ACHV |
| Unified Institutional Score Composite Signal | 56.6 / 100 (HOLD) | 32.2 / 100 (SELL) | Higher Composite | ACHV |